title: A novel CYP2C9 variant that caused erroneous genotyping in a patient on warfarin therapy.
authors.affiliation: Kinki Central Hospital, Itami, Hyogo 664-8533, Japan.
authors.forename: Rika
authors.initials: R
authors.lastname: Okuda
authors.forename: Hiromi
authors.initials: H
authors.lastname: Izumoto
authors.forename: Masaki
authors.initials: M
authors.lastname: Nishiki
authors.forename: Kayo
authors.initials: K
authors.lastname: Matsuura
authors.forename: Keisuke
authors.initials: K
authors.lastname: Matsuzaki
authors.forename: Tomoyuki
authors.initials: T
authors.lastname: Uemichi
authors.forename: Tomokazu
authors.initials: T
authors.lastname: Suzuki
mesh_terms: D000368:Aged; D000925:Anticoagulants / Q000378:metabolism*; D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics* / Q000378:metabolism*; D001483:Base Sequence; D065729:Cytochrome P-450 CYP2C9; D004247:DNA / Q000235:genetics; D017931:DNA Primers / Q000235:genetics; D005260:Female; D014644:Genetic Variation; D005838:Genotype; D006801:Humans; D008297:Male; D010375:Pedigree; D016133:Polymerase Chain Reaction; D012150:Polymorphism, Restriction Fragment Length; D014859:Warfarin / Q000378:metabolism*
chemical_list: D000925:Anticoagulants; D017931:DNA Primers; D014859:Warfarin; D004247:DNA; C450260:CYP2C9 protein, human; D065729:Cytochrome P-450 CYP2C9; D001189:Aryl Hydrocarbon Hydroxylases